Sectors
EVMN
Evommune, Inc.
14.07
1 x 12.22
1 x 14.82
bid
ask
-
0.05
0.35%
1 @ 04:00 PM
14.07 +0.00 (0.00%)
| Ytd | -17.82% | |
| 1y | -30.45% |
14.06
day range
14.59
11.05
52 week range
31.57
| Open | 14.14 | Prev Close | 14.12 | Low | 14.06 | High | 14.59 | Mkt Cap | 510.63M |
| Vol | 345.22K | Avg Vol | 805.12K | EPS | -10.14 | P/E | -1.39 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 15.73 | 200-d Avg | 20.46 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 34.90M | ||
| Research and Development Expense | 26.41M | ||
| Selling, General and Administrative Expense | 8.48M | ||
| Operating Income | -34.90M | ||
| Net Income | -32.25M | ||
| Net Income Common Stock | -32.25M | ||
| Net Income Common Stock (USD) | -32.25M | ||
| Consolidated Income | -32.25M | ||
| Earnings per Basic Share | -0.89 | ||
| Earnings per Basic Share (USD) | -0.89 | ||
| Earnings per Diluted Share | -0.89 | ||
| Earning Before Interest & Taxes (EBIT) | -32.25M | ||
| Earning Before Interest & Taxes (USD) | -32.25M | ||
| Weighted Average Shares | 36.14M | ||
| Weighted Average Shares Diluted | 36.14M | ||
| Balance Sheet | |||
| Cash and Equivalents | 61.24M | ||
| Cash and Equivalents (USD) | 61.24M | ||
| Investments | 227.97M | ||
| Investments Current | 140.76M | ||
| Investments Non-Current | 87.21M | ||
| Current Assets | 204.25M | ||
| Property, Plant & Equipment Net | 9.22M | ||
| Total Assets | 301.95M | ||
| Debt Current | 1.24M | ||
| Total Debt | 8.11M | ||
| Current Liabilities | 17.49M | ||
| Debt Non-Current | 6.87M | ||
| Total Liabilities | 24.36M | ||
| Accumulated Retained Earnings (Deficit) | -275.01M | ||
| Shareholders Equity | 277.59M | ||
| Shareholders Equity (USD) | 277.59M | ||
| Assets Non-Current | 97.70M | ||
| Total Debt (USD) | 8.11M | ||
| Liabilities Non-Current | 6.87M | ||
| Trade and Non-Trade Payables | 5.04M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 552.00K | ||
| Net Cash Flow from Financing | 532.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 11.51M | ||
| Capital Expenditure | -183.00K | ||
| Issuance (Purchase) of Equity Shares | 674.00K | ||
| Issuance (Repayment) of Debt Securities | -142.00K | ||
| Net Cash Flow from Investing | 31.29M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 31.48M | ||
| Net Cash Flow from Operations | -20.32M | ||
| Share Based Compensation | 4.60M | ||